ATP synthase Fo subunit
    21.
    发明授权
    ATP synthase Fo subunit 失效
    ATP合酶Fo亚基

    公开(公告)号:US5962646A

    公开(公告)日:1999-10-05

    申请号:US216625

    申请日:1998-12-16

    IPC分类号: A61K38/00 C12N9/14 C07K14/00

    CPC分类号: C12N9/14 A61K38/00

    摘要: The present invention provides a human ATP synthase d subunit (ASYSD) and polynucleotides which encode ASYSD. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides to methods for producing ASYSD and for treating disorders associated with expression of ASYSD.

    摘要翻译: 本发明提供了人ATP合成酶d亚基(ASYSD)和编码ASYSD的多核苷酸。 本发明还提供表达载体,宿主细胞,激动剂,反义分子,抗体或拮抗剂。 本发明还提供了用于产生ASYSD和用于治疗与ASYSD表达相关的疾病的方法。

    DNA encoding human metallothionein
    22.
    发明授权
    DNA encoding human metallothionein 失效
    编码人金属硫蛋白的DNA

    公开(公告)号:US5955428A

    公开(公告)日:1999-09-21

    申请号:US123850

    申请日:1997-07-28

    CPC分类号: C07K14/825 A61K38/00

    摘要: The present invention provides a human metallothionein (HMBP-I) and polynucleotides which identify and encode HMBP-I. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HMBP-I and a method for producing HMBP-I. The invention also provides for agonists, antibodies, or antagonists specifically binding HMBP-I, and their use, in the prevention and treatment of diseases associated with expression of HMBP-I. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HMBP-I for the treatment of diseases associated with the expression of HMBP-I. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HMBP-I.

    摘要翻译: 本发明提供人金属硫蛋白(HMBP-1)和识别和编码HMBP-1的多核苷酸。 本发明还提供了包含编码HMBP-1的核酸序列和生产HMBP-1的方法的遗传工程表达载体和宿主细胞。 本发明还提供了特异性结合HMBP-1的激动剂,抗体或拮抗剂及其用于预防和治疗与HMBP-1表达有关的疾病的用途。 此外,本发明提供了反义分子用于编码HMBP-1的多核苷酸用于治疗与HMBP-1表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合HMBP-1的抗体的诊断测定法。

    Method of screening for ATP synthase Fo subunit
    23.
    发明授权
    Method of screening for ATP synthase Fo subunit 失效
    筛选ATP合酶Fo亚基的方法

    公开(公告)号:US5948625A

    公开(公告)日:1999-09-07

    申请号:US94080

    申请日:1998-06-09

    CPC分类号: C12N9/14 A61K38/00

    摘要: The present invention provides a human ATP synthase d subunit (ASYSD) and polynucleotides which encode ASYSD. The invention also provides expression vectors, host cells, agonists, antisense molecules, antibodies, or antagonists. The invention also provides methods for producing ASYSD and for treating disorders associated with expression of ASYSD.

    摘要翻译: 本发明提供了人ATP合成酶d亚基(ASYSD)和编码ASYSD的多核苷酸。 本发明还提供表达载体,宿主细胞,激动剂,反义分子,抗体或拮抗剂。 本发明还提供了用于产生ASYSD和用于治疗与ASYSD表达相关的疾病的方法。

    CDNA encoding a LEA-motif developmental protein homologous to avian px19
    25.
    发明授权
    CDNA encoding a LEA-motif developmental protein homologous to avian px19 失效
    CDNA编码与禽类px19同源的LEA基序发育蛋白

    公开(公告)号:US5858712A

    公开(公告)日:1999-01-12

    申请号:US796676

    申请日:1997-02-06

    CPC分类号: C07K14/4702 A61K38/00

    摘要: px19 is an avian gene recently identified as a bromodexoyuridine (BrdU)-sensitive transcript associated with hematopoiesis in early chick development. Its translation product contains an "LEA" (late embryogenesis abundant) motif which had previously been observed only in plant seed proteins. The present invention provides nucleic acids encoding a human LEA motif protein (HuLEAP) homologous to the avian px19 gene product. Also provided are expression vectors, transformed host cells, and methods of using them to produce recombinant HuLEAP polypeptides.

    摘要翻译: px19是一种禽类基因,最近被鉴定为与早期小鸡发育中造血作用相关的溴代维甲酸(BrdU)敏感转录物。 其翻译产品含有以前仅在植物种子蛋白中观察到的“LEA”(晚期胚胎发生丰富)基序。 本发明提供编码与禽类px19基因产物同源的人LEA基序蛋白(HuLEAP)的核酸。 还提供了表达载体,转化的宿主细胞和使用它们产生重组HuLEAP多肽的方法。

    Proline-rich acidic protein
    26.
    发明授权
    Proline-rich acidic protein 失效
    脯氨酸丰富的酸性蛋白

    公开(公告)号:US5856139A

    公开(公告)日:1999-01-05

    申请号:US815175

    申请日:1997-03-11

    CPC分类号: C07K14/47

    摘要: The present invention provides a human proline-rich acidic protein (PRAP) and polynucleotides which identify and encode PRAP. In addition, the invention provides expression vectors and host cells, agonists, antibodies, or antagonists. This invention also provides methods for preventing or treating disorders associated with the expression of PRAP.

    摘要翻译: 本发明提供了富含脯氨酸的酸性蛋白(PRAP)和识别和编码PRAP的多核苷酸。 此外,本发明提供表达载体和宿主细胞,激动剂,抗体或拮抗剂。 本发明还提供了预防或治疗与PRAP表达相关的疾病的方法。

    Human selenoprotein
    27.
    发明授权

    公开(公告)号:US5856131A

    公开(公告)日:1999-01-05

    申请号:US807043

    申请日:1997-02-24

    CPC分类号: C07K14/47 A61K38/00

    摘要: The present invention provides a human selenoprotein (HSEL) and polynucleotides which identify and encode HSEL. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HSEL and a method for producing HSEL. The invention also provides for agonists, antibodies, or antagonists specifically binding HSEL, and their use, in the prevention and treatment of diseases associated with expression of HSEL. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HSEL for the treatment of diseases associated with the expression of HSEL. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HSEL.

    Human apoptosis regulator
    28.
    发明授权
    Human apoptosis regulator 失效
    人类凋亡调节因子

    公开(公告)号:US5847093A

    公开(公告)日:1998-12-08

    申请号:US773910

    申请日:1996-12-27

    CPC分类号: C07K14/47 A61K38/00

    摘要: The present invention provides a human apoptosis regulator protein (APRG) and polynucleotides which identify and encode APRG. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding APRG and a method for producing APRG. The invention also provides for agonists, antibodies, or antagonists specifically binding APRG, and their use, in the prevention and treatment of diseases associated with expression of APRG. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding APRG for the treatment of diseases associated with the expression of APRG. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding APRG.

    摘要翻译: 本发明提供了鉴定和编码APRG的人细胞凋亡调节蛋白(APRG)和多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码APRG的核酸序列和生产APRG的方法。 本发明还提供了特异性结合APRG的激动剂,抗体或拮抗剂及其在预防和治疗与APRG表达相关的疾病中的用途。 此外,本发明提供了反义分子用于编码APRG的多核苷酸用于治疗与APRG表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合APRG的抗体的诊断测定法。

    Subunits of NADH dehydrogenase
    29.
    发明授权

    公开(公告)号:US5814451A

    公开(公告)日:1998-09-29

    申请号:US785065

    申请日:1997-01-17

    CPC分类号: C12N9/0036 A61K38/00

    摘要: The present invention provides four NADH dehydrogenase subunits (designated individually as NDS-1, NDS-2, NDS-3, and NDS-4 and collectively as NDS) and polynucleotides which identify and encode NDS. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NDS and a method for producing NDS. The invention also provides for use of NDS and agonists, antibodies, or antagonists specifically binding NDS, in the prevention and treatment of diseases associated with expression of NDS. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NDS for the treatment of diseases associated with the expression of NDS. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NDS.

    Human membrane protein
    30.
    发明授权
    Human membrane protein 失效
    人膜​​蛋白

    公开(公告)号:US5763589A

    公开(公告)日:1998-06-09

    申请号:US781562

    申请日:1997-01-09

    CPC分类号: C07K14/705

    摘要: The present invention provides a novel human integral membrane (IMP) and polynucleotides which identify and encode IMP. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding IMP and a method for producing IMP. The invention also provides for agonists, antibodies, or antagonists specifically binding IMP, and their use, in the prevention and treatment of diseases associated with expression of IMP. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding IMP for the treatment of diseases associated with the expression of IMP. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding IMP.

    摘要翻译: 本发明提供了一种新型人体内膜(IMP)和识别和编码IMP的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码IMP的核酸序列和产生IMP的方法。 本发明还提供特异性结合IMP的激动剂,抗体或拮抗剂及其在预防和治疗与IMP表达有关的疾病中的用途。 另外,本发明提供了反义分子用于编码IMP的多核苷酸用于治疗与IMP表达相关的疾病。 本发明还提供利用多核苷酸或其片段或其互补体和特异性结合IMP的抗体的诊断测定法。